Honghui Capital Completes First Close of RMB Fund III, Raising Nearly 70% of Target Size

VCBeat (WeChat: vcbeat) has learned that following the closure of its second U.S. dollar fund in 2017, Hui Capital launched the fundraising for its third RMB fund in September 2018. With strong support from both new and existing limited partners (LPs), the Hui team worked diligently to complete the first closing recently. The total amount raised in this initial closing accounts for nearly 70% of the fund’s target size, with subsequent fundraising efforts proceeding in an orderly manner. Meanwhile, the fund’s first key investment project, Borui Medicine, has also been completed.

Here, the Honghui Team expresses its deep gratitude to our existing Limited Partners (LPs) for their trust, and extends sincere appreciation to our new LPs for their choice. As the Lunar New Year ushers in a fresh start and renewed vitality, the Honghui Team will forge ahead with determination, working diligently to contribute our full strength to China’s healthcare industry.

Hui Capital is a leading investment platform in China’s healthcare industry. Managing both USD and RMB funds, Hui Capital oversees total assets exceeding RMB 7 billion. Its investment focus spans biopharmaceuticals, medical devices, and healthcare services.

Current successful investments include a portfolio comprising: Mindray Medical (300760), Yuwell Medical (002223), WuXi AppTec (603259), Linhua Medical (835637), Pharmaron (832159), Kintor Pharmaceutical (839419), Pharmaron Beijing, Baiyang Pharma, Sansure Biotech, JetMed Medical, Kangtuo Medical, Malo Clinic, Little White Rabbit Dental, Chaoju Eye Care, Dr. Cui Yutao Children's Health Management Center, and Petshin/Weishi, among other high-quality enterprises.

Honghui Capital upholds the spirit of “professionalism, prudence, and innovation,” dedicating itself to serving entrepreneurs and founders in the health sector, and jointly building an industrial investment platform shared by all entrepreneurs and investors in the healthcare industry.